Marc Carrier/LinkedIn;Caterina E. Marx
/researchgate.net
Apr 17, 2026, 12:44
Marc Carrier: A Practical Approach to Recurrent Thrombosis in Cancer Patients
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Managing recurrent VTE despite anticoagulation in patients with cancer remains one of the most challenging scenarios in thrombosis care.
This ‘How I Treat’ review outlines a pragmatic potential approach:
- Confirm true recurrence (versus residual clot)
- Assess adherence, drug interactions, and absorption
- Optimize anticoagulation (LMWH escalation or switch)
Despite these strategies, recurrence and bleeding risks remain substantial highlighting the urgent need for more high-quality data.”
Title: How I treat breakthrough thrombosis in patients with cancer
Authors: Caterina E. Marx, Marc Carrier

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 15:02Sham Zamil: The Role of ABO Compatibility in Platelet Pooling
-
Jul 21, 2026, 13:43Dima Shulkin: Assessing AI-Driven Blood Test Screening for Colorectal Cancer
-
Jul 21, 2026, 13:24Benoit Mores: National Initiative Targets Better Cardiovascular Outcomes
-
Jul 21, 2026, 13:10Paolo Zamboni: Chronic Cerebrospinal Venous Insufficiency Hypothesis in Multiple Sclerosis
-
Jul 21, 2026, 13:05Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
-
Jul 21, 2026, 13:00Kefah Mokbel: Beyond Thromboprophylaxis – Enoxaparin’s Emerging Anticancer Signal
-
Jul 21, 2026, 12:56Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
-
Jul 21, 2026, 12:53Sandrine Bouteille: A Milestone Presentation at ISTH 2026
-
Jul 21, 2026, 12:40Kalled Musallam: A Comprehensive Review of Thalassemia